Nasraway S - Search Results

1

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R, et al. Abraham E, et al. Among authors: nasraway s. JAMA. 1995 Mar 22-29;273(12):934-41. JAMA. 1995. PMID: 7884952 Clinical Trial.

2

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.

Abraham E, Anzueto A, Gutierrez G, Tessler S, San Pedro G, Wunderink R, Dal Nogare A, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pennington J, Porter S. Abraham E, et al. Among authors: nasraway s. Lancet. 1998 Mar 28;351(9107):929-33. Lancet. 1998. PMID: 9734938 Clinical Trial.

3

IL-1ra administration does not improve cardiac function in patients with severe sepsis.

Vincent JL, Slotman G, Van Leeuwen PA, Shelly M, Nasraway S, Tenaillon A, Bander J, Friedman G. Vincent JL, et al. Among authors: nasraway s. J Crit Care. 1999 Jun;14(2):69-72. doi: 10.1016/s0883-9441(99)90016-3. J Crit Care. 1999. PMID: 10382786 Clinical Trial.

4

The problems and challenges of immunotherapy in sepsis.

Nasraway SA. Nasraway SA. Chest. 2003 May;123(5 Suppl):451S-9S. doi: 10.1378/chest.123.5_suppl.451s. Chest. 2003. PMID: 12740228 Review.

5

Candidemia as a cause of septic shock and multiple organ failure in nonimmunocompromised patients.

Hadley S, Lee WW, Ruthazer R, Nasraway SA Jr. Hadley S, et al. Among authors: nasraway sa jr. Crit Care Med. 2002 Aug;30(8):1808-14. doi: 10.1097/00003246-200208000-00023. Crit Care Med. 2002. PMID: 12163798 Clinical Trial.

6

Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study.

Krinsley JS, Egi M, Kiss A, Devendra AN, Schuetz P, Maurer PM, Schultz MJ, van Hooijdonk RT, Kiyoshi M, Mackenzie IM, Annane D, Stow P, Nasraway SA, Holewinski S, Holzinger U, Preiser JC, Vincent JL, Bellomo R. Krinsley JS, et al. Among authors: nasraway sa. Crit Care. 2013 Mar 1;17(2):R37. doi: 10.1186/cc12547. Crit Care. 2013. PMID: 23452622 Free PMC article.

7

Hypotension during slow phenytoin infusion in severe sepsis.

Isenstein D, Nasraway SA. Isenstein D, et al. Among authors: nasraway sa. Crit Care Med. 1990 Sep;18(9):1036-8. doi: 10.1097/00003246-199009000-00023. Crit Care Med. 1990. PMID: 2394103 No abstract available.

8

Roundtable debate: Controversies in the management of the septic patient--desperately seeking consensus.

Waxman AB, Ward N, Thompson T, Lilly CM, Lisbon A, Hill N, Nasraway SA, Heard S, Corwin H, Levy M. Waxman AB, et al. Among authors: nasraway sa. Crit Care. 2005 Aug 20;9(1):E1. doi: 10.1186/cc2940. Crit Care. 2005. PMID: 15693960 Free PMC article.

9

Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: an executive summary. Society of Critical Care Medicine.

Shapiro BA, Warren J, Egol AB, Greenbaum DM, Jacobi J, Nasraway SA, Schein RM, Spevetz A, Stone JR. Shapiro BA, et al. Among authors: nasraway sa. Crit Care Med. 1995 Sep;23(9):1601-5. doi: 10.1097/00003246-199509000-00022. Crit Care Med. 1995. PMID: 7664564

10

Sepsis research: we must change course.

Nasraway SA Jr. Nasraway SA Jr. Crit Care Med. 1999 Feb;27(2):427-30. doi: 10.1097/00003246-199902000-00054. Crit Care Med. 1999. PMID: 10075072 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters